BATS BZX Real-Time Price
As of 2:20pm ET
| -0.61 / -0.79%|
The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 90.00, with a high estimate of 116.00 and a low estimate of 65.00. The median estimate represents a +17.65% increase from the last price of 76.50.
The current consensus among 5 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.